Infection Clinical Trial
Official title:
Daytime Variation of Complication in Gastric and Pancreatic Surgery : a Single Center Randomized Study
Evaluate the daytime variation of complications in gastric and pancreatic surgery
Status | Not yet recruiting |
Enrollment | 200 |
Est. completion date | June 1, 2018 |
Est. primary completion date | June 1, 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 70 Years |
Eligibility |
Inclusion Criteria: 1. Patients who will undergo gastric or pancreatic surgery in our department. 2. Voluntary participation, Signing informed consent and have good compliance. Exclusion Criteria: 1. Patient who attended other clinical trials in the last two months. 2. Patient who will undergo multiple organs resection. 3. Patient who has been taken anticoagulant recently. |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Cancer Institute and Hospital, Chinese Academy of Medical Sciences |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | gastrointestinal dysfunction | using clinical symptoms to evaluate the gastrointestinal function after surgery | after operation from date of randomization until the date of first documented complications or date of death from any cause, whichever came first,up to 24 weeks | |
Primary | hemorrhage | using clinical symptoms to evaluate the gastrointestinal function after surgery | after operation from date of randomization until the date of first documented complications or date of death from any cause, whichever came first, up to 24 weeks | |
Primary | infection | using clinical symptoms to evaluate the gastrointestinal function after surgery | after operation from date of randomization until the date of first documented complications or date of death from any cause, whichever came first, up to 24 weeks | |
Primary | anastomotic fistula | using clinical symptoms to evaluate the gastrointestinal function after surgery | after operation from date of randomization until the date of first documented complications or date of death from any cause, whichever came first,up to 24 weeks | |
Primary | test rating | collecting blood sample to evaluate change of test after surgery | after operation from date of randomization until the date of first documented complications or date of death from any cause, whichever came first, up to 24 weeks | |
Secondary | Physical fitness index | The recovery of physical fitness index | after operation from date of randomization until the date of first documented complications or date of death from any cause, whichever came first,up to 24 weeks. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04529421 -
Assocation Between In-person Instruction and COVID-19 Risk
|
||
Recruiting |
NCT04081792 -
Optimal Antibiotics for Operated Diabetic Foot Infections
|
N/A | |
Completed |
NCT04332861 -
Evaluation of Infection in Obstructing Urolithiasis
|
||
Recruiting |
NCT04674657 -
Does Extra-Corporeal Membrane Oxygenation Alter Antiinfectives Therapy Pharmacokinetics in Critically Ill Patients
|
||
Enrolling by invitation |
NCT05052203 -
Researching the Effects of Sepsis on Quality Of Life, Vitality, Epigenome and Gene Expression During RecoverY From Sepsis
|
||
Recruiting |
NCT00342589 -
New Techniques for Using a Saline Wash as a Diagnostic Tool for Pneumocystis Pneumonia
|
||
Completed |
NCT03295825 -
Heparin Binding Protein in Early Sepsis Diagnosis
|
N/A | |
Completed |
NCT03296423 -
Bacillus Calmette-guérin Vaccination to Prevent Infections of the Elderly
|
Phase 4 | |
Withdrawn |
NCT04217252 -
Clinical Application of High-throughput Sequencing Technology for the Diagnosis of Patients With Severe Infection
|
N/A | |
Recruiting |
NCT02905552 -
Myelodysplasic Syndromes and Risk Factors for Infection
|
N/A | |
Recruiting |
NCT02899143 -
Short-course Antimicrobial Therapy in Sepsis
|
Phase 2 | |
Withdrawn |
NCT02904434 -
Gastrointestinal Implications of Voriconazole Exposure
|
||
Active, not recruiting |
NCT02768454 -
Antimicrobials Stewardship by Pharmacist
|
N/A | |
Completed |
NCT02219776 -
Decreasing Infection In Arthroscopic Shoulder Surgery
|
N/A | |
Completed |
NCT02210169 -
RCT of Continuous Versus Intermittent Infusion of Vancomycin in Neonates
|
N/A | |
Recruiting |
NCT02098226 -
Evaluation of MALDI Biotyper CA System for Detection of Gram- and Gram+ Bacteria and Yeasts
|
N/A | |
Completed |
NCT01846832 -
A Study of TMC435 Plus Pegylated Interferon Alfa-2a and Ribavirin in Participants With Chronic HCV Infection
|
Phase 3 | |
Terminated |
NCT01441206 -
Safety and Pharmacokinetics of Single and Multiple Dose Rifampin in Infants
|
Phase 1 | |
Completed |
NCT01434797 -
Value of PET/CT Imaging in the Diagnosis of Permanent Central Venous Catheters Infection
|
||
Completed |
NCT01159834 -
Human Papillomavirus (HPV) Vaccination in Barretos (Pio XII Foundation - Barretos Cancer Hospital)
|
N/A |